Resolution of neuropathies caused by bortezomib and its successor drugs

The project aims to understand and promote the resolution of neuropathies caused by the proteasome inhibitor bortezomib (BTZ) and its successor drugs.

By integrating clinical, genetic, and biomarker data, the goal is to develop a predictive risk tool for bortezomib-induced peripheral neuropathy (BIPN) and to identify mechanisms that drive pain resolution.

 

Background

Bortezomib is a widely used treatment for multiple myeloma, but its neurotoxic effects significantly limit its long-term use. BIPN, characterized by sensory disturbances and pain, occurs in up to 30% of patients, with some experiencing persistent symptoms even after treatment cessation. In the first funding period (FP1), the project identified neurofilament light chain (NfL) as a marker of acute axonal damage and discovered genetic and inflammatory markers associated with BIPN severity. The need for targeted prevention and resolution strategies remains critical.

Research Objective

This project will refine and validate a predictive "BIPN Risk Tool" that integrates clinical and genetic markers to identify high-risk patients early. We will further compare the mechanisms of nerve damage caused by BTZ and its successor drugs, including immune mechanisms, genetic and epigenetic factors and pharmacokinetics.

Significance

By identifying biomarkers and genetic predispositions for BIPN, this project aims to enable early intervention and personalized treatment strategies.

Research Team P1

Head

Univ.-Prof. Dr. Martin Kortüm, MD
Chair of Translational Myeloma Research
University Hospital Würzburg

Univ.-Prof. Dr. Hermann Einsele, MD
Professor and Chair of the Department of Internal Medicine II
University Hospital Würzburg

Univ.-Prof. Dr. Claudia Sommer, MD
Speaker of KFO 5001
Department of Neurology and Department of Anesthesiology
University Hospital Würzburg

Members of the team

Dr. rer. nat. Umair Munawar, Researcher

Dr. Xiang Zhou, MD, Clinician Scientist

Nadine Cebulla, PhD Student

Leon Flamm, PhD Student

Nicola Giordani, PhD Student

Johanna Güse, PhD Student

Seungbin Han, PhD Student

Laura-Isabel Jähnel, PhD Student

Calvin Terhorst, PhD Student

Annett Wieser, PhD Student

Felicitas Schoch, PhD Student

Marie-Luise Reinle, PhD Student

Contact

Portraitfoto: Univ.-Prof. Dr. med. Martin Kortüm

Univ.-Prof. Dr.
Martin Kortüm, MD

PI Project Bortezomib (P1)

+49 931 201-40001

Portraitfoto: Univ.-Prof. Dr. med. Claudia Sommer

Univ.-Prof. Dr.
Claudia Sommer, MD

Speaker of the Clinical Research Unit

+49 931 201-23763

Portraitfoto von Univ.-Prof. Dr. med. Hermann Einsele

Univ.-Prof. Dr.
Hermann Einsele, MD

PI Project Bortezomib (P1)

+49 931 201-40001

schließen